Clinical evaluation of molecular surrogate subtypes in patients with ipsilateral multifocal primary breast cancer

Clinical evaluation of molecular surrogate subtypes in patients with ipsilateral multifocal primary breast cancer

Abstract Background When ipsilateral multifocal primary breast cancer (IMBC) is detected, standard routine is to evaluate the largest tumor with immunohistochemistry (IHC). As all foci are not routinely characterized, many patients may not receive optimal adjuvant treatment. Here, we assess the clin...

Full description

Bibliographic Details
Main Authors: Slavica Janeva, Ellen Krabbe, Toshima Z. Parris, Salmir Nasic, Marie Sundquist, Per Karlsson, Riccardo A. Audisio, Roger Olofsson Bagge, Anikó Kovács
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Breast Cancer Research
Subjects:
Multifocal breast cancer
Multicentric breast cancer
Biomarkers
Breast cancer subtypes
Adjuvant treatment
Synchronous
Online Access:https://doi.org/10.1186/s13058-023-01632-5

Internet

https://doi.org/10.1186/s13058-023-01632-5

Similar Items